Evoke Wealth’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.65M | Buy |
13,147
+1,317
| +11% | +$165K | 0.04% | 177 |
|
|
2025
Q1 | $1.62M | Buy |
11,830
+262
| +2% | +$35.9K | 0.04% | 152 |
|
|
2024
Q4 | $1.77M | Buy |
11,568
+112
| +1% | +$17.1K | 0.05% | 140 |
|
|
2024
Q3 | $2.22M | Buy |
11,456
+7,916
| +224% | +$1.53M | 0.06% | 115 |
|
|
2024
Q2 | $821K | Sell |
3,540
-7,288
| -67% | -$1.69M | 0.97% | 20 |
|
|
2024
Q1 | $2.33M | Buy |
+10,828
| New | +$2.33M | 0.07% | 100 |
|
|
2023
Q2 | – | Sell |
-7,069
| Closed | -$1.97M | – | 366 |
|
|
2023
Q1 | $1.97M | Buy |
7,069
+5
| +0.1% | +$1.39K | 0.07% | 108 |
|
|
2022
Q4 | $1.96M | Buy |
+7,064
| New | +$1.96M | 0.07% | 116 |
|
|
2022
Q2 | – | Sell |
-362
| Closed | -$76K | – | 1177 |
|
|
2022
Q1 | $76K | Buy |
362
+324
| +853% | +$68K | ﹤0.01% | 467 |
|
|
2021
Q4 | $9K | Hold |
38
| – | – | ﹤0.01% | 800 |
|
|
2021
Q3 | $10K | Sell |
38
-12
| -24% | -$3.16K | ﹤0.01% | 737 |
|
|
2021
Q2 | $17K | Buy |
50
+5
| +11% | +$1.7K | ﹤0.01% | 675 |
|
|
2021
Q1 | $13K | Hold |
45
| – | – | ﹤0.01% | 646 |
|
|
2020
Q4 | $11K | Hold |
45
| – | – | ﹤0.01% | 569 |
|
|
2020
Q3 | $13K | Hold |
45
| – | – | ﹤0.01% | 524 |
|
|
2020
Q2 | $12K | Sell |
45
-3
| -6% | -$800 | ﹤0.01% | 524 |
|
|
2020
Q1 | $15.2K | Sell |
48
-392
| -89% | -$124K | ﹤0.01% | 469 |
|
|
2019
Q4 | $131K | Sell |
440
-747
| -63% | -$222K | 0.02% | 288 |
|
|
2019
Q3 | $276K | Buy |
+1,187
| New | +$276K | 0.03% | 212 |
|